BioCardia, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 11, 2026 (16 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 24, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jun 9, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Sep 22, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Dec 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Nov 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Oct 28, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Aug 21, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Aug 16, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $25 | 44% |
| Jul 26, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| May 29, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Nov 14, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Oct 11, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Sep 6, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $4 | 44% |
| Aug 10, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Jul 24, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Jun 21, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| May 11, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Mar 30, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $9 | 44% |
| Nov 11, 2022 | Dawson James | downgrade | Buy → Neutral | $0 | — |
| Dec 20, 2021 | HC Wainwright & Co. | initiate | — → Buy | $9 | 44% |
| Apr 16, 2021 | Dawson James | downgrade | Buy → Neutral | $0 | — |
| Sep 21, 2020 | Alliance Global Partners | initiate | — → Buy | $11.5 | 41% |
| Nov 26, 2019 | Brookline Capital | initiate | — → Buy | $22 | 38% |
| Oct 10, 2019 | Maxim Group | initiate | — → Buy | $9 | 42% |
No cross-platform signals in the last 90 days